|
(PQB6) Genetics of Subclonal Evolution in Pancreatic Cancer
|
1R01CA179991-01
|
$336,150
|
IACOBUZIO-DONAHUE, CHRISTINE
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQD6) Muscle stem cells and cancer cachexia
|
1R01CA180057-01
|
$358,226
|
GUTTRIDGE, DENIS
|
OHIO STATE UNIVERSITY
|
|
A Drosophila Model Linking Diet-induced Obesity and Cancer (PQ 1)
|
5R01CA170495-02
|
$330,610
|
Cagan, Ross
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
A Model for Preclinical Biomarker Discovery in Pancreatic Ductal Adenocarcinoma
|
5K08CA137153-04
|
$163,080
|
Collisson, Eric
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A novel murine model for metastatic islet cell pancreas cancer
|
5R21CA164795-02
|
$188,490
|
GROSS, KENNETH
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
A RAS-FAM83A Regulatory Loop as a Novel Therapeutic Target for Pancreatic Cancer
|
1R21CA178651-01
|
$206,843
|
Jackson, Mark
|
CASE WESTERN RESERVE UNIVERSITY
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,117,473
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-37S2
|
$12,499
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-37
|
$7,216,850
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Ack1: A Critical Regulator of Hormone-Refractory Prostate Cancer
|
5R01CA135328-04
|
$304,764
|
Mahajan, Nupam
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
ACOSOG Community Clinical Oncology Program (CCOP) Research Base
|
5U10CA149950-03
|
$1,055,550
|
Sloan, Jeff
|
MAYO CLINIC ROCHESTER
|
|
ACOSOG Competing Renewal
|
5U10CA076001-17
|
$2,940,780
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
ADAM17 in pancreatic cancer and pancreatitis
|
5R01CA159222-03
|
$366,727
|
CRAWFORD, HOWARD
|
MAYO CLINIC JACKSONVILLE
|
|
Adoption and Retooling of GEM model for Pancreatic Cancer
|
ZIA BC 011463
|
$48,590
|
Van Dyke, Terry
|
CCR (NCI)
|
|
Advanced Development of a Multiplexed SERS-based Biomarker Detection Platform: A
|
5R33CA155586-03
|
$307,490
|
Porter, Marc
|
UNIVERSITY OF UTAH
|
|
Advanced Glycation End-Products and Risk of Pancreatic Cancer
|
1R01CA172880-01A1
|
$524,349
|
JIAO, LI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Advancing Clinical Trails in Coastal North Carolina
|
1U10CA176852-01
|
$532,663
|
MAGUIRE, PATRICK
|
NEW HANOVER REGIONAL MEDICAL CENTER
|
|
Aldo-keto reductase family 1 member B10 AKR1B10 in pancreatic carcinogenesis
|
5R01CA164041-02
|
$304,278
|
YANG, GUANG-YU
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Alternative splicing in Ras transformed cells
|
ZIA BC 011397
|
$94,660
|
Luo, Ji
|
CCR (NCI)
|
|
American College of Radiology Imaging Network
|
3U10CA080098-14S2
|
$5,146,722
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Amplification of tumor hypoxic responses by MIF-dependent HIF stabilization
|
5R01CA129967-05
|
$280,014
|
MITCHELL, ROBERT
|
UNIVERSITY OF LOUISVILLE RES FDN
|
|
An epigenetic switch controlling pancreatic cancer susceptibility
|
1R21CA179453-01
|
$208,871
|
MURTAUGH, LEWIS
|
UNIVERSITY OF UTAH
|
|
An integrated computational and functional genomics discovery engine for preclini
|
1U01CA176303-01
|
$1,088,820
|
KEMP, CHRISTOPHER
|
FRED HUTCHINSON CAN RES CTR
|
|
Annexin A2 as a mediator of pancreatic cancer metastases
|
1R01CA169702-01A1
|
$336,150
|
Zheng, Lei
|
JOHNS HOPKINS UNIVERSITY
|
|
Anti-pancreatic tumorigenesis by inactivation of SAG/RBX2 E3 ubiquitin ligase
|
1R21CA170995-01A1
|
$202,928
|
SUN, YI
|
UNIVERSITY OF MICHIGAN
|
|
Anti-PV1 Therapy for Pancreatic Cancer
|
1R21CA172983-01A1
|
$211,410
|
STAN, RADU
|
DARTMOUTH COLLEGE
|
|
Anti-Tumor Mechanisms and Therapeutic Effects of Vitamin D
|
5R01CA067267-19
|
$410,953
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S1
|
$75,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-35
|
$3,676,771
|
CRESS, ANNE
|
UNIVERSITY OF ARIZONA
|
|
ASCORBATE-INDUCED RADIOSENSITIZATION IN PANCREATIC CANCER
|
5U01CA166800-02
|
$185,232
|
CULLEN, JOSEPH
|
UNIVERSITY OF IOWA
|
|
Aspects of MUC13 Mucin in Cancer
|
5R01CA142736-04
|
|
Chauhan, Subhash
|
SANFORD RESEARCH/USD
|
|
Aspects of MUC13 Mucin in Cancer
|
7R01CA142736-05
|
$295,230
|
Chauhan, Subhash
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,207,080
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Autophagy in Pancreatic Neuroendocrine Tumor Growth and Metastasis
|
1R21CA173348-01A1
|
$242,461
|
Du, Yi-Chieh Nancy
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Axl as a target for the therapy of pancreatic cancer
|
1R21CA173487-01
|
$207,495
|
BREKKEN, ROLF
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,465,171
|
Custer, Mary
|
CCR (NCI)
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S1
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S2
|
$43,265
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-07
|
$3,092,811
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$708,251
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biochemical and molecular studies on NQO1. Design of less toxic Hsp90 inhibitors
|
2R01CA051210-21
|
$323,289
|
ROSS, DAVID
|
UNIVERSITY OF COLORADO DENVER
|
|
Biological Activity of Ras Oncogenes
|
5R01CA042978-27
|
$335,477
|
DER, CHANNING
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Biology and Immunology of Pancreatic Cancer Stem Cells in a Novel Mouse Model
|
5U01CA141468-05
|
$443,110
|
ENGLEMAN, EDGAR G.
|
STANFORD UNIVERSITY
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$336,277
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biomarkers for the Early Detection of Pancreatic Cancer
|
5U01CA111302-09
|
$561,227
|
KILLARY, ANN
|
UT MD ANDERSON CANCER CTR
|
|
Biostatistics Data Management Center for ACRIN
|
3U10CA079778-14S1
|
$2,271,308
|
Gatsonis, Constantine
|
BROWN UNIVERSITY
|
|
Black/White PHS Study
|
ZIA CP010136-00430
|
$163,230
|
Silverman, Debra
|
DCEG (NCI)
|
|
Breakdown of Desmoplasia in Pancreatic Cancer to Enhance Drug Effectiveness
|
1R21CA173518-01A1
|
$184,590
|
BOUCHER, YVES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$845,663
|
Restifo, Nicholas
|
CCR (NCI)
|
|
C-Src Kinase-Calmodulin Interaction: A Therapeutic Target For Pancreatic Cancer
|
1R21CA176267-01
|
$199,839
|
KRISHNA, NEPALLI
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|